| Name | 5-Chloro-1-[(1S)-1-cyclopropylethyl]-3-{[2,6-dichloro-4-(difluoro methoxy)phenyl]amino}-2(1H)-pyrazinone |
|---|---|
| Synonyms |
1-Boc-D-Pyroglutamic acid ethyl ester
Ethyl Boc-D-pyroglutamate Ethyl N-Boc-D-pyroglutamate |
| Description | BMS-665053 is a corticotropin-releasing factor-1 (CRF1) receptor antagonist (IC50 = 1.0 nM). BMS-665053)11 is a potent inhibitor of CRF-stimulated cyclic adenosine monophosphate (cAMP) production in human Y-79 retinoblastoma cells (IC50 = 4.9 nM)[1]. |
|---|---|
| Related Catalog | |
| References |
| Molecular Formula | C16H14Cl3F2N3O2 |
|---|---|
| Molecular Weight | 424.65700 |
| Exact Mass | 423.01200 |
| PSA | 59.38000 |
| LogP | 4.94140 |
| Precursor 4 | |
|---|---|
| DownStream 0 | |